Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 4/20 | 0.40 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.40 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.40 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | HRH2 | P25021 | 1/20 | 0.35 |
| ▸ | NAMPT | P43490 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7304737 | 0.95 | EPHX2 (0.39) | EPHX2MAPK10MAPK14NPC1RAB9A | |
| SCHEMBL7312049 | 0.92 | EPHX2 (0.46) | EPHX2MAPK10MAPK14HRH2NAMPT | |
| SCHEMBL9865426 | 0.91 | NAMPT (0.38) | NAMPT | |
| SCHEMBL7431291 | 0.90 | EPHX2 (0.41) | EPHX2NPC1RAB9AHRH2 | |
| SCHEMBL7431296 | 0.90 | EPHX2 (0.41) | EPHX2NPC1RAB9AHRH2 | |
| SCHEMBL9867599 | 0.87 | NPY1R (0.39) | NAMPT | |
| SCHEMBL7311277 | 0.87 | CNR1 (0.38) | EPHX2SLC6A9NPC1RAB9AHRH2 | |
| SCHEMBL9867594 | 0.86 | NPY1R (0.40) | — | |
| SCHEMBL9866135 | 0.85 | EPHX2 (0.41) | EPHX2NPC1RAB9AHRH2 | |
| SCHEMBL9866130 | 0.85 | EPHX2 (0.41) | EPHX2NPC1RAB9AHRH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0262448-A1 | Imidazolylguanidine derivatives, process for their preparation and medicines containing them | HEUMANN PHARMA GMBH & CO (DE) | 1988-04-06 | — | — | EP | disclosed |